Gensight Biologics SA (SIGHT) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	24.00K	24.00K	302.00K	302.00K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	2.14M	2.14M	1.08M	1.08M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.28M	1.28M	1.36M	1.36M
Operating expense	3.42M	3.42M	2.43M	2.43M
Total operating expenses	3.42M	3.42M	2.43M	2.43M
Operating income	-3.40M	-3.40M	-2.13M	-2.13M
Other non operating income	697.00K	697.00K	436.00K	436.00K
EBT including unusual items	-3.49M	-3.49M	-2.53M	-2.53M
EBT excluding unusual items	-3.49M	-3.49M	-2.53M	-2.53M
Income tax expense	-4.50K	-4.50K	2.00K	2.00K
Effective tax rate	0.13%	0.13%	-0.08%	-0.08%
Other operating expenses	-	-	-	-
Net income	-3.48M	-3.48M	-2.53M	-2.53M
Net profit margin	-14,514.58%	-14,514.58%	-839.24%	-839.24%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-660.00K	-660.00K	-784.50K	-784.50K
Net interest expenses	-660.00K	-660.00K	-784.50K	-784.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.36M	-3.36M	-2.09M	-2.09M
Gain or loss from assets sale	-	-	-	-

Finance